메뉴 건너뛰기




Volumn 22, Issue 3, 2010, Pages 201-204

Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate

Author keywords

Megestrol acetate; Metastatic breast cancer; Metronomic chemo hormonal therapy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MEGESTROL ACETATE; PROGESTERONE RECEPTOR;

EID: 78650253350     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2010.22.3.201     Document Type: Article
Times cited : (30)

References (22)
  • 1
    • 68449084678 scopus 로고    scopus 로고
    • Metastatic breast cancer: Therapeutic options according to molecular subtypes and prior adjuvant therapy
    • Guarneri V, Conte P. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist 2009; 14(7): 645-656.
    • (2009) Oncologist , vol.14 , Issue.7 , pp. 645-656
    • Guarneri, V.1    Conte, P.2
  • 2
    • 10444284584 scopus 로고    scopus 로고
    • 54th edition, Megestrol acetate British Medical Association and Royal Pharmaceutical Society of Great Britain
    • British National Formulary (54th edition, 2007). Megestrol acetate British Medical Association and Royal Pharmaceutical Society of Great Britain.
    • (2007) British National Formulary
  • 3
    • 0023914450 scopus 로고
    • An overview of megestrol acetate for the treatment of advanced breast cancer
    • Sedlacek SM. An overview of megestrol acetate for the treatment of advanced breast cancer. Semin Oncol 1988; 15 (2 Suppl 1): 3-13.
    • (1988) Semin Oncol , vol.15 , Issue.2 SUPPL. 1 , pp. 3-13
    • Sedlacek, S.M.1
  • 4
    • 0030845035 scopus 로고    scopus 로고
    • Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor- Positive metastatic breast cancer: A southwest oncology group phase III trial
    • Russel CA, Green SJ, O'Sullivan J, Hynes HE, Budd GT, Congdon JE et al. Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial. J Clin Oncol 1997; 15 (7): 2494-2501. (Pubitemid 27289877)
    • (1997) Journal of Clinical Oncology , vol.15 , Issue.7 , pp. 2494-2501
    • Russell, C.A.1    Green, S.J.2    O'Sullivan, J.3    Hynes, H.E.4    Budd, G.T.5    Congdon, J.E.6    Martino, S.7    Osborne, C.K.8
  • 7
    • 12944279734 scopus 로고    scopus 로고
    • Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer
    • DOI 10.1046/j.1439-0353.2005.04048.x
    • Gille J, Spieth K, Kaufmann R. Metronomic low-dose chemotherapy as antiangiogenetic therapeutic strategy for cancer. J Dtsch Dermatol Ges 2005; 3 (1): 26-32. (Pubitemid 40175154)
    • (2005) JDDG - Journal of the German Society of Dermatology , vol.3 , Issue.1 , pp. 26-32
    • Gille, J.1    Spieth, K.2    Kaufmann, R.3
  • 8
    • 0035214416 scopus 로고    scopus 로고
    • Metronomic scheduling: The future of chemotherapy?
    • Gasparini G. Metronomic scheduling: the future of chemotherapy? Lancet Oncol 2001; 2 (12): 733-740.
    • (2001) Lancet Oncol , vol.2 , Issue.12 , pp. 733-740
    • Gasparini, G.1
  • 12
    • 33750693021 scopus 로고    scopus 로고
    • A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients
    • Correale P, Cerretani D, Remondo C, Martellucci I, Marsili S, La Placa M et al. A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients. Oncol Rep 2006; 16(1): 133-140.
    • (2006) Oncol Rep , vol.16 , Issue.1 , pp. 133-140
    • Correale, P.1    Cerretani, D.2    Remondo, C.3    Martellucci, I.4    Marsili, S.5    La Placa, M.6
  • 13
    • 33846515135 scopus 로고    scopus 로고
    • Weekly Docetaxel and Epirubicin in Treatment of Advanced Hormone-Refractory Prostate Cancer
    • DOI 10.1016/j.urology.2006.09.015, PII S0090429506021376
    • Petrioli R, Paolelli L, Francini E, Manganelli A, Salvestrini F, Francini G. Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer. Urology 2007; 69 (1): 142-146. (Pubitemid 46161681)
    • (2007) Urology , vol.69 , Issue.1 , pp. 142-146
    • Petrioli, R.1    Paolelli, L.2    Francini, E.3    Manganelli, A.4    Salvestrini, F.5    Francini, G.6
  • 14
    • 0035049886 scopus 로고    scopus 로고
    • Chemotherapy of metastatic breast cancer: What to expect in 2001 and beyond
    • DOI 10.1634/theoncologist.6-2-133
    • Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN. Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 2001; 6 (2): 133-146. (Pubitemid 32323452)
    • (2001) Oncologist , vol.6 , Issue.2 , pp. 133-146
    • Esteva, F.J.1    Valero, V.2    Pusztai, L.3    Boehnke-Michaud, L.4    Buzdar, A.U.5    Hortobagyi, G.N.6
  • 15
    • 0036392350 scopus 로고    scopus 로고
    • Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens
    • Francini G, Petrioli R, Messinese S, Pozzessere D, Marsili S, Correale P et al. Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens. Cancer Chemother Pharmacol 2002; 50 (4): 271-276.
    • (2002) Cancer Chemother Pharmacol , vol.50 , Issue.4 , pp. 271-276
    • Francini, G.1    Petrioli, R.2    Messinese, S.3    Pozzessere, D.4    Marsili, S.5    Correale, P.6
  • 16
    • 33645992772 scopus 로고    scopus 로고
    • Third-line hormonal treatment with exemestane in post-menopausal patients with advanced breast cancer progressing on letrazole or anastrazole. A phase II trial conducted by the Ellenic group of oncology (HELGO)
    • Gennatas C, Michalaki V, Carvounis E, Psychogios J, Poulakaki N, Katsiamis G et al. Third-line hormonal treatment with exemestane in post-menopausal patients with advanced breast cancer progressing on letrazole or anastrazole. A phase II trial conducted by the Ellenic group of oncology (HELGO). Tumori 2006; 92 (1): 13-17.
    • (2006) Tumori , vol.92 , Issue.1 , pp. 13-17
    • Gennatas, C.1    Michalaki, V.2    Carvounis, E.3    Psychogios, J.4    Poulakaki, N.5    Katsiamis, G.6
  • 17
    • 0036373257 scopus 로고    scopus 로고
    • Monotherapy with paclitaxel as third-line chemotherapy against anthracycline-pretreated and docetaxel-refractory metastatic breast cancer
    • Kinoshita J, Haga S, Shimizu T, Imamura H, Watanabe O, Nagumo H et al. Monotherapy with paclitaxel as third-line chemotherapy against anthracycline-pretreated and docetaxel-refractory metastatic breast cancer. Breast Cancer 2002: 9 (2): 166-169.
    • (2002) Breast Cancer , vol.9 , Issue.2 , pp. 166-169
    • Kinoshita, J.1    Haga, S.2    Shimizu, T.3    Imamura, H.4    Watanabe, O.5    Nagumo, H.6
  • 18
    • 0028812586 scopus 로고
    • Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: A randomized study comparing low versus high doses of cisplatin
    • Ceci G, Bisagni G, Cocconi G, Rodinò C, Belsanti V, Bertusi M et al. Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: a randomized study comparing low versus high doses of cisplatin. Tumori 1995; 81 (4): 241-244.
    • (1995) Tumori , vol.81 , Issue.4 , pp. 241-244
    • Ceci, G.1    Bisagni, G.2    Cocconi, G.3    Rodinò, C.4    Belsanti, V.5    Bertusi, M.6
  • 19
    • 21844436308 scopus 로고    scopus 로고
    • Megestrol acetate for the treatment of anorexia-cachexia syndrome
    • CD004310
    • Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005 (2): CD004310.
    • (2005) Cochrane Database Syst Rev , Issue.2
    • Berenstein, E.G.1    Ortiz, Z.2
  • 20
    • 0028257911 scopus 로고
    • Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide
    • Brufman G, Isacson R, Haim N, Gez E, Sulkes A. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide. Oncology 1994; 51(3): 258-261. (Pubitemid 24113209)
    • (1994) Oncology , vol.51 , Issue.3 , pp. 258-261
    • Brufman, G.1    Isacson, R.2    Haim, N.3    Gez, E.4    Sulkes, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.